According to the International Energy Agency, the rapid growth of solar energy generation puts renewables on track to meet almost half of global electricity demand by 2030.

Researchers at Binghamton University’s Thomas J. Watson College of Engineering and Applied Science want to ensure that solar panels are not causing a pollution problem like the fossil fuels they are replacing. 

A Georgia State University doctoral student has been named the Global Champion of D3CODE 2025, an international challenge recognizing groundbreaking student-led solutions at the intersection of AI, quantum computing and intelligent data ecosystems.

A new study has uncovered alarming evidence that bisphenols (BPs) —plastic-related chemicals known to disrupt hormones—are accumulating and magnifying through Arctic food webs. 

Artificial intelligence (AI) is profoundly transforming the paradigm of solid tumor drug development. By integrating multi-omics data, spatial transcriptomics, and advanced computational models, AI has significantly accelerated the discovery and validation of new targets, compressing the traditional ten-year research and development cycle to two to three years. Generative AI platforms have optimized small molecule inhibitors, biologics, and messenger RNA vaccines, achieving breakthroughs in overcoming tumor heterogeneity, improving efficacy, and predicting drug resistance. However, clinical translation still faces challenges such as data bias, algorithm transparency, and the validation gap between models and real-world human experience. This review aims to systematically elaborate on the transformative role of AI in solid tumor drug development and to promote interdisciplinary cooperation as well as the construction of ethical frameworks to enable the full realization of precision oncology.